Hras helps hippo heterodimerize to evade tumor suppression

Area of Science:

• Cell biology
• Molecular oncology
• Tumor suppressor pathways

Background:

• Ras oncoproteins have complex roles in apoptosis, with mechanisms poorly understood.
• The Hippo pathway, regulating organ size, is linked to Ras signaling.
• Mammalian Ste20-like kinases (Msts) -1 and -2 form homo- and heterodimers, regulating pathway activity.

Purpose of the Study:

• To investigate the mechanism by which Ras oncoproteins interact with the Hippo pathway.
• To elucidate the role of Mst1/Mst2 heterodimer formation in Ras-mediated cellular effects.

Main Methods:

• Analysis of Ras oncoprotein interactions with Mst1 and Mst2.
• Investigating the role of Erk activation in Mst complex formation.
• Assessing the kinase activity of Mst1/Mst2 heterodimers compared to homodimers.

Main Results:

• Activated Hras promotes Mst1/Mst2 heterodimer formation, dependent on Erk activation.
• Mst1/Mst2 heterodimers exhibit significantly lower kinase activity than Mst1/Mst1 or Mst2/Mst2 homodimers.
• Heterodimer formation is essential for Hippo pathway deactivation and Hras-driven cell transformation.

Conclusions:

• Ras-mediated regulation of the Hippo pathway involves the formation of less active Mst1/Mst2 heterodimers.
• This mechanism is critical for overcoming tumor suppressor functions and promoting oncogenesis.